Akums Drugs & Pharmaceuticals: Pioneering Global Expansion in CDMO

Akums Drugs & Pharmaceuticals: Pioneering Global Expansion in CDMO

Akums Drugs & Pharmaceuticals: Pioneering Global Expansion in CDMO Akums Drugs and Pharmaceuticals Ltd., India's largest CDMO, has made significant strides in its financial and operational performance for Q4 and FY25. The company reported a 12.4% year-on-year increase in revenue, reaching Rs.1,073 crore in the fourth quarter, driven by strategic global expansions and innovation efforts.The fiscal year highlights include a pivotal €200 million co…

Akums Reports Q4 FY25 with 12.4% Revenue Growth, FY25 Adj. EBITDA Remained Strong at 12.3% - The Times of Bengal

Akums Drugs and Pharmaceuticals Ltd., India’s largest contract development and manufacturing organization (CDMO), has announced its consolidated financial results for the quarter and fiscal year ending March 31, 2025. The fourth quarter marked a significant rebound in performance, laying a strong foundation for continued growth and global expansion. In Q4 FY25, Akums reported revenue of Rs.1,073 crore, reflecting a robust 12.4% year-on-year (YoY…

Pharma Sector’s Rising Stars: Are They the Next Big Wealth Builders?

India’s Pharma Sector Grows 7.8% in April 2025, Backed by Government Schemes and Rising Domestic Demand India’s pharmaceutical sector is undergoing a significant transformation. Once primarily known for producing affordable generic medicines, it is now emerging as a hub for innovation, specialty drugs, and global expansion. This evolution is driven by strategic government initiatives, robust domestic demand, and favorable international trade agr…